Navigation Links
Labopharm to Present Poster on Dose Titration of Once-daily,Tramadol at 3rd International Forum on Pain Medicine

m those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process and the commercialization of the Company's products, if they are approved, specifically, the adoption of such products by physicians and patients.. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.

CONTACT: At Labopharm, Mark D'Souza, Chief Financial Officer, Tel: (450)686-0207; At The Equicom Group, Jason Hogan, Media and Investor Relations,Tel: (416) 815-0700, ; French: Eric Bouchard, Tel:(514) 208-5939, jhogan@equicomgroup.com ebouchard@equicomgroup.com

Ticker Symbol: (Toronto:DDS.),(NASDAQ-NMS:DDSS)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
10. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
(Date:12/1/2009)... , BOSTON, Dec. 1 /PRNewswire-FirstCal...tion (Nasdaq: PRXL ), a leading global biopharmac...ssion on innovative approaches to drug development...ia Pacific Conference, being held December 1-3, 20...EXEL is a sponsor of the conference, which is focu...
(Date:11/30/2009)... , SAN CARLOS, Calif., Nov. 30 /PRNewswire-F...today announced the promotion of Lorianne Masuoka,...fficer. Dr. Masuoka will report directly to Nekta...W. Robin. ,, "Lorianne,s outstanding leadersh...egies have been instrumental in rapidly advancing ...
(Date:11/30/2009)... , TORONTO, Nov. 30 The Special.... ("Patheon" or the "Company") (TSX: PTI) and JLL ...ings, LLC (collectively, "JLL"), today announced t...ment agreement in respect of the pending legal act...rovides among other things that: ,, until Marc...
Breaking Medicine Technology:PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3CyberKnife Treatment for Medically Inoperable Lung Cancer 56512 1CyberKnife Treatment for Medically Inoperable Lung Cancer 56512 2Cobb Pediatric Therapy Services Is Recognized by Inc Magazine as One of the Fastest Growing Private Companies 56510 1Cobb Pediatric Therapy Services Is Recognized by Inc Magazine as One of the Fastest Growing Private Companies 56510 2Raleigh Comprehensive and Cosmetic Dentistry Announces Addition of New Practice to Raleigh Dentist Family 56508 1Raleigh Comprehensive and Cosmetic Dentistry Announces Addition of New Practice to Raleigh Dentist Family 56508 2
...ire-FirstCall/ -- The,first of two stages of the P...mada,s Alpha-1 Antitrypsin (AAT) liquid drug,candi...ectronic,nebulizer for the treatment of patients s...d resulted in good safety profiles,and patient tol...opment of aerosolized AAT delivered with an optimi...
...Conference on Avian,Influenza at France,s Pasteur ...all/ -- Very low doses of,Novavax Inc.,s pandemic ...thal challenge of live H5N1 viruses, according to,...nd International,Conference on Avian Influenza in ...es of Novavax,s,virus-like particle (VLP) H5N1 vac...
Other Medicine Technology:PARI and Kamada Announce Positive Intermediate Phase I Results for,Inhaled Alpha-1 Antitrypsin 2PARI and Kamada Announce Positive Intermediate Phase I Results for,Inhaled Alpha-1 Antitrypsin 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 4
(Date:12/1/2009)... Global measles deaths drop worldwide,...cus) December 1, 2009 -- WHAT: Measles Initiativ...s for Disease Control and Prevention, the United N...ganization – will announce the latest global...on Thursday, December 3, 2009 at 10:00 a.m. ET/16:...
(Date:12/1/2009)...DDISON, Texas, Dec. 1 For many emp...lth care is more than just an employee benefit, it...oyees. Hobby Lobby Stores, Inc. is leading this ef...ksite health and wellness center at its corporate ...re services directly to employees and their depend...
(Date:12/1/2009)..., RANCHO SANTA FE, Calif., Dec. 1 /PRNewswire/ -...the ingredient in grapes acclaimed for its potenti...it the marketplace. ,, (Photo: http://www.news...go: http://www.newscom.com/cgi-bin/prnh/20091111/...Bar, developed by ResVez, Inc. of Rancho Santa Fe,...
(Date:12/1/2009)... , MILWAUKEE, Dec. 1 F...t is the ability to earn an income. It is this a... not only pay today,s mortgage but also to plan an.... ,, Yet, according to a Northwestern Mutual...er have taken measures to protect their income by ...
(Date:12/1/2009)..., SAN DIEGO, Dec. 1 US ... Farming, Nursery and Wellness products is pleased...ith Southern California Micro-Lending Institution:... Skwara, CEO of US Farms, Inc. stated, "We are ple...th Angels in Action utilizing our Aloe365.com prod...
Breaking Medicine News(10 mins):Health News:**MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health 2Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3Health News:First Resveratrol Nutrition Bar Hits the Market 2Health News:Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 2Health News:Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk 3Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 3
... have revealed that an 'early warning signal' in t...s. The study has discovered a mechanism in the br... have resulted in us making errors in the past. ...tial predictions are correct. The element of surpr...
...rleukin-12 (IL-12),that may provide resistance aga...the immune system responds to a food protein as if...globulin E (IgE) antibodies, which normally help t...was conducted by a team of researchers led by Dr C...
...uggests that 90 per cent of youngsters, aged 16 to...ullness of hearing or ringing in the ears-after a...1 people, more than half of whom visited a bar whe...such places was too loud, one-third believed that ...
...ining from drugs has been nailed . Hilton,...told Larry King during her post-prison interview t..., multiple sources have confirmed the socialites c...gh her list of celebrity appearances. Mean...
...atoid arthritis (RA) face different treatment opti...sing . Two new studies examined patients decisions...nd found that most RA patients are reluctant to ch...nt advances in RA treatment include multi-drug the...
...ystatin C, used to test for early-stage kidney i...hose at risk of developing a condition known as p... the University at Buffalo has shown. Pre-...sorbed properly by cells. An estimated 54...
Other Medicine News:Health News:This is How We Learn from Our Past Mistakes 2Health News:Alternative Treatments for Arthritis 2Health News:Alternative Treatments for Arthritis 3Health News:Early Indicator of Kidney Disease May Also Predict Risk of Pre-Diabetes 2
...ert Detection Reagents provide molecular labs a mo...says. By using our MGB technology, combined with p...is now able to provide molecular labs more powerfu...ecific organisms or genetic mutations associated w...
ICON® Mono
ICON II hCG
Drugs of Abuse Array Evidence Phencyclidine Assay
Medicine Products: